发明名称 |
MODIFIED PEPTIDE, CB RECEPTOR LIGAND, KIT, IN VITRO PROCESS FOR EVALUATING CB RECEPTOR BONDS, USES, PHARMACEUTICAL COMPOSITION FOR MODULATING CB RECEPTOR ACTIVITY |
摘要 |
The present invention discloses novel non-natural and modified peptides acting as cannabinoid (CB) receptors ligands, especially CB1 and/or CB2, useful as modulators of its activity; they are also described as a kit and a process in vitro for evaluating the binding to CB receptors, uses and pharmaceutical composition for modulating the CB receptors activity. The invention covers the non-natural peptide of SeqID:1 and those having at least 70% similarity related to the same, including as achievements specialty useful of the invention the non-natural peptides of SeqID:2, SeqID:3, SeqID:4, SeqID:5, SeqlD:6. |
申请公布号 |
EP2878306(A1) |
申请公布日期 |
2015.06.03 |
申请号 |
EP20130816344 |
申请日期 |
2013.07.12 |
申请人 |
PROTEIMAX BIOTECNOLOGIA LTDA |
发明人 |
STERMAN HEIMANN, ANDREA |
分类号 |
A61K38/17;A61P3/04;C07K7/06;C07K7/08 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|